{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T04:44:29Z","timestamp":1789447469013,"version":"build-2803163510"},"reference-count":66,"publisher":"Oxford University Press (OUP)","issue":"10","license":[{"start":{"date-parts":[[2015,4,18]],"date-time":"2015-04-18T00:00:00Z","timestamp":1429315200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,10,1]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title>\u2003<\/jats:title>\n                    <jats:p>Hypocalcemia and hyperphosphatemia are encountered in idiopathic hypoparathyroidism (IHP) and pseudohypoparathyroidism type Ib (PHP1B). In contrast to PHP1B, which is caused by resistance toward parathyroid hormone (PTH), the genetic defects leading to IHP impair production of this important regulator of mineral ion homeostasis. So far, only five PTH mutations were shown to cause IHP, each of which is located in the hormone's pre-pro leader segment and thus impair hormone secretion. In three siblings affected by IHP, we now identified a homozygous arginine-to-cysteine mutation at position 25 (R25C) of the mature PTH(1-84) polypeptide; heterozygous family members are healthy. Depending on the assay used for evaluating these patients, plasma PTH levels were either low or profoundly elevated, thus leading to ambiguities regarding the underlying diagnosis, namely IHP or PHP1B. Consistent with increased PTH levels, recombinant [Cys25]PTH(1-84) and wild-type PTH(1-84) were secreted equally well by transfected COS-7 cells. However, synthetic [Cys25]PTH(1-34) was found to have a lower binding affinity for the PTH receptor type-1 (PTH1R) than PTH(1-34) and consequently a lower efficiency for stimulating cAMP formation in cells expressing this receptor. Consistent with these in vitro findings, long-term infusion of [Cys25]PTH(1-34) resulted only in minimal calcemic and phosphaturic responses, despite readily detectable levels of [Cys25]PTH(1-34) in plasma. The mineral ion abnormalities observed in the three IHP patients are thus most likely caused by the inherited homozygous missense PTH mutation, which reduces bioactivity of the secreted hormone. Based on these findings, screening for PTH(1-84) mutations should be considered when clinical and laboratory findings are consistent with PHP1B, but GNAS methylation changes have been excluded. Differentiating between IHP and PHP1B has considerable implications for genetic counseling, therapy, and long-term outcome because treatment of IHP patients with inappropriately high doses of active vitamin D and calcium can contribute to development of nephrocalcinosis and chronic kidney disease. \u00a9 2015 American Society for Bone and Mineral Research.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1002\/jbmr.2532","type":"journal-article","created":{"date-parts":[[2015,4,18]],"date-time":"2015-04-18T18:37:11Z","timestamp":1429382231000},"page":"1803-1813","source":"Crossref","is-referenced-by-count":82,"title":["A Homozygous [Cys25]PTH(1-84) Mutation That Impairs PTH\/PTHrP Receptor Activation Defines a Novel Form of Hypoparathyroidism"],"prefix":"10.1093","volume":"30","author":[{"given":"Sihoon","family":"Lee","sequence":"first","affiliation":[{"name":"Department of Internal Medicine and Laboratory of Molecular EndocrinologyGachon University School of MedicineIncheonSouth Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Mannstadt","sequence":"additional","affiliation":[{"name":"Endocrine UnitMassachusetts General Hospital and Harvard Medical SchoolBostonMAUSA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Guo","sequence":"additional","affiliation":[{"name":"Endocrine UnitMassachusetts General Hospital and Harvard Medical SchoolBostonMAUSA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seul Min","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine and Laboratory of Molecular EndocrinologyGachon University School of MedicineIncheonSouth Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyon-Seung","family":"Yi","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine and Laboratory of Molecular EndocrinologyGachon University School of MedicineIncheonSouth Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashok","family":"Khatri","sequence":"additional","affiliation":[{"name":"Endocrine UnitMassachusetts General Hospital and Harvard Medical SchoolBostonMAUSA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Dean","sequence":"additional","affiliation":[{"name":"Endocrine UnitMassachusetts General Hospital and Harvard Medical SchoolBostonMAUSA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto","family":"Okazaki","sequence":"additional","affiliation":[{"name":"Endocrine UnitMassachusetts General Hospital and Harvard Medical SchoolBostonMAUSA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas J","family":"Gardella","sequence":"additional","affiliation":[{"name":"Endocrine UnitMassachusetts General Hospital and Harvard Medical SchoolBostonMAUSA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harald","family":"J\u00fcppner","sequence":"additional","affiliation":[{"name":"Pediatric Nephrology UnitMassachusetts General Hospital and Harvard Medical SchoolBostonMAUSA"},{"name":"Endocrine UnitMassachusetts General Hospital and Harvard Medical SchoolBostonMAUSA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2015,4,18]]},"reference":[{"key":"2024020319023760800_jbmr2532-bib-0001","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1152\/physrev.2001.81.1.239","article-title":"Extracellular calcium sensing and extracellular calcium signaling","volume":"81","author":"Brown","year":"2001","journal-title":"Physiol Rev"},{"key":"2024020319023760800_jbmr2532-bib-0002","doi-asserted-by":"crossref","first-page":"2768","DOI":"10.1093\/hmg\/dds105","article-title":"Identification of 70 calcium-sensing receptor mutations in hyper- and hypo-calcaemic patients: evidence for clustering of extracellular domain mutations at calcium-binding sites","volume":"21","author":"Hannan","year":"2012","journal-title":"Hum Mol Genet"},{"key":"2024020319023760800_jbmr2532-bib-0003","doi-asserted-by":"crossref","first-page":"3884","DOI":"10.1210\/jc.2013-2158","article-title":"Calcium-sensing receptor autoantibodies and idiopathic hypoparathyroidism","volume":"98","author":"Tomar","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"2024020319023760800_jbmr2532-bib-0004","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1172\/JCI200113180","article-title":"Familial isolated hypoparathyroidism caused by a mutation in the gene for the transcription factor GCMB","volume":"108","author":"Ding","year":"2001","journal-title":"J Clin Invest"},{"key":"2024020319023760800_jbmr2532-bib-0005","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1136\/jmg.2004.026898","article-title":"Identification of a novel mutation disrupting the DNA binding activity of GCM2 in autosomal recessive familial isolated hypoparathyroidism","volume":"42","author":"Baumber","year":"2005","journal-title":"J Med Genet"},{"key":"2024020319023760800_jbmr2532-bib-0006","doi-asserted-by":"crossref","first-page":"2487","DOI":"10.1210\/jc.2004-2450","article-title":"GCMB mutation in familial isolated hypoparathyroidism with residual secretion of parathyroid hormone","volume":"90","author":"Thomee","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"2024020319023760800_jbmr2532-bib-0007","doi-asserted-by":"crossref","first-page":"3568","DOI":"10.1210\/jc.2007-2167","article-title":"Dominant-negative GCMB mutations cause an autosomal dominant form of hypoparathyroidism","volume":"93","author":"Mannstadt","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"2024020319023760800_jbmr2532-bib-0008","doi-asserted-by":"crossref","first-page":"3512","DOI":"10.1210\/jc.2009-2532","article-title":"A missense glial cells missing homolog B (GCMB) mutation, Asn502His, causes autosomal dominant hypoparathyroidism","volume":"95","author":"Mirczuk","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"2024020319023760800_jbmr2532-bib-0009","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1530\/EJE-09-0303","article-title":"Presence and significance of a R110W mutation in the DNA-binding domain of GCM2 gene in patients with isolated hypoparathyroidism and their family members","volume":"162","author":"Tomar","year":"2010","journal-title":"Eur J Endocrinol"},{"key":"2024020319023760800_jbmr2532-bib-0010","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1111\/j.1365-2265.2011.04256.x","article-title":"Identification and characterization of C106R, a novel mutation in the DNA-binding domain of GCMB, in a family with autosomal-dominant hypoparathyroidism","volume":"76","author":"Yi","year":"2012","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2024020319023760800_jbmr2532-bib-0011","doi-asserted-by":"crossref","first-page":"2476","DOI":"10.1056\/NEJMoa1300253","article-title":"Mutations affecting G-protein subunit alpha11 in hypercalcemia and hypocalcemia","volume":"368","author":"Nesbit","year":"2013","journal-title":"N Engl J Med"},{"key":"2024020319023760800_jbmr2532-bib-0012","doi-asserted-by":"crossref","first-page":"2532","DOI":"10.1056\/NEJMc1300278","article-title":"Germline mutations affecting Galpha11 in hypoparathyroidism","volume":"368","author":"Mannstadt","year":"2013","journal-title":"N Engl J Med"},{"key":"2024020319023760800_jbmr2532-bib-0013","doi-asserted-by":"crossref","first-page":"E1774","DOI":"10.1210\/jc.2014-1029","article-title":"Autosomal dominant hypoparathyroidism caused by germline mutation in GN A11: phenotypic and molecular characterization","volume":"99","author":"Li","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"2024020319023760800_jbmr2532-bib-0014","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1172\/JCI114811","article-title":"Mutation of the signal peptide-encoding region of the preproparathyroid hormone gene in familial isolated hypoparathyroidism","volume":"86","author":"Arnold","year":"1990","journal-title":"J Clin Invest"},{"key":"2024020319023760800_jbmr2532-bib-0015","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1038\/ng0592-149","article-title":"A donor splice site mutation in the parathyroid hormone gene is associated with autosomal recessive hypoparathyroidism","volume":"1","author":"Parkinson","year":"1992","journal-title":"Nat Genet"},{"key":"2024020319023760800_jbmr2532-bib-0016","first-page":"3792","article-title":"A novel mutation of the signal peptide of the preproparathyroid hormone gene associated with autosomal recessive familial isolated hypoparathyroidism","volume":"84","author":"Sunthornthepvarakul","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"2024020319023760800_jbmr2532-bib-0017","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.bone.2012.06.009","article-title":"A novel homozygous mutation in the parathyroid hormone gene (PTH) in a girl with isolated hypoparathyroidism","volume":"51","author":"Ertl","year":"2012","journal-title":"Bone"},{"key":"2024020319023760800_jbmr2532-bib-0018","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/B978-012098651-4\/50053-5","volume-title":"The parathyroids: basic and clinical concepts","author":"Jan de Beur","year":"2001"},{"key":"2024020319023760800_jbmr2532-bib-0019","first-page":"675","article-title":"Endocrine manifestations of stimulatory G protein alpha-subunit mutations and the role of genomic imprinting","volume":"22","author":"Weinstein","year":"2001","journal-title":"Endocr Rev"},{"key":"2024020319023760800_jbmr2532-bib-0020","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1016\/B978-1-4160-5583-9.00065-4","volume-title":"Endocrinology","author":"Bastepe","year":"2010","edition":"6th ed"},{"key":"2024020319023760800_jbmr2532-bib-0021","doi-asserted-by":"crossref","first-page":"3020","DOI":"10.1210\/jc.2011-1048","article-title":"Clinical review: pseudohypoparathyroidism: diagnosis and treatment","volume":"96","author":"Mantovani","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"2024020319023760800_jbmr2532-bib-0022","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/ijo.2009.222","article-title":"The role of GNAS and other imprinted genes in the development of obesity","volume":"34","author":"Weinstein","year":"2010","journal-title":"Int J Obes (Lond)"},{"key":"2024020319023760800_jbmr2532-bib-0023","doi-asserted-by":"crossref","first-page":"4736","DOI":"10.1210\/jc.2002-020183","article-title":"The gsalpha gene: predominant maternal origin of transcription in human thyroid gland and gonads","volume":"87","author":"Mantovani","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"2024020319023760800_jbmr2532-bib-0024","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1002\/jbmr.2070","article-title":"Postnatal establishment of allelic G\u03b1s silencing as a plausible explanation for delayed onset of parathyroid hormone resistance owing to heterozygous galphas disruption","volume":"29","author":"Turan","year":"2014","journal-title":"J Bone Miner Res"},{"key":"2024020319023760800_jbmr2532-bib-0025","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1172\/JCI19159","article-title":"Autosomal dominant pseudohypoparathyroidism type Ib is associated with a heterozygous microdeletion that likely disrupts a putative imprinting control element of GNAS","volume":"112","author":"Bastepe","year":"2003","journal-title":"J Clin Invest"},{"key":"2024020319023760800_jbmr2532-bib-0026","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1086\/429932","article-title":"A novel STX16 deletion in autosomal dominant pseudohypoparathyroidism type Ib redefines the boundaries of a cis-acting imprinting control element of GNAS","volume":"76","author":"Linglart","year":"2005","journal-title":"Am J Hum Genet"},{"key":"2024020319023760800_jbmr2532-bib-0027","doi-asserted-by":"crossref","first-page":"3993","DOI":"10.1210\/jc.2009-2205","article-title":"Deletion of the noncoding GNAS antisense transcript causes pseudohypoparathyroidism type Ib and biparental defects of GNAS methylation in cis","volume":"95","author":"Chillambhi","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"2024020319023760800_jbmr2532-bib-0028","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/j.1365-2265.2011.04026.x","article-title":"Clinical characterization and identification of two novel mutations of the GNAS gene in patients with pseudohypoparathyroidism and pseudopseudohypoparathyroidism","volume":"75","author":"Jin","year":"2011","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2024020319023760800_jbmr2532-bib-0029","doi-asserted-by":"crossref","first-page":"E1507","DOI":"10.1210\/jc.2011-1411","article-title":"Madelung-like deformity in pseudohypoparathyroidism type 1b","volume":"96","author":"Sanchez","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"2024020319023760800_jbmr2532-bib-0030","doi-asserted-by":"crossref","first-page":"E2314","DOI":"10.1210\/jc.2012-2920","article-title":"De novo STX16 deletions: an infrequent cause of pseudohypoparathyroidism type Ib that should be excluded in sporadic cases","volume":"97","author":"Turan","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"2024020319023760800_jbmr2532-bib-0031","doi-asserted-by":"crossref","first-page":"E863","DOI":"10.1210\/jc.2011-2804","article-title":"A new deletion ablating NESP55 causes loss of maternal imprint of A\/B GNAS and autosomal dominant pseudohypoparathyroidism type Ib","volume":"97","author":"Richard","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"2024020319023760800_jbmr2532-bib-0032","first-page":"jc20133704","article-title":"Autosomal dominant pseudohypoparathyroidism type Ib: a novel inherited deletion ablating STX16 causes loss of imprinting at the A\/B DMR","author":"Elli","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"2024020319023760800_jbmr2532-bib-0033","doi-asserted-by":"crossref","first-page":"3738","DOI":"10.1210\/jc.2007-0869","article-title":"Genetic analysis and evaluation of resistance to thyrotropin and growth hormone-releasing hormone in pseudohypoparathyroidism type Ib","volume":"92","author":"Mantovani","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"2024020319023760800_jbmr2532-bib-0034","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1111\/j.1365-2265.2007.02969.x","article-title":"Similar clinical and laboratory findings in patients with symptomatic autosomal dominant and sporadic pseudohypoparathyroidism type Ib despite different epigenetic changes at the GNAS locus","volume":"67","author":"Linglart","year":"2007","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2024020319023760800_jbmr2532-bib-0035","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1210\/jc.2009-0176","article-title":"Pseudohypoparathyroidism and GNAS epigenetic defects: clinical evaluation of Albright hereditary osteodystrophy and molecular analysis in 40 patients","volume":"95","author":"Mantovani","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"2024020319023760800_jbmr2532-bib-0036","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1002\/jbmr.408","article-title":"Exclusion of the GNAS locus in PHP-Ib patients with broad GNAS methylation changes: evidence for an autosomal recessive form of PHP-Ib?","volume":"26","author":"Fern\u00e1ndez-Rebollo","year":"2011","journal-title":"J Bone Miner Res"},{"key":"2024020319023760800_jbmr2532-bib-0037","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1136\/jmg.2010.081356","article-title":"Quantification of the methylation at the GNAS locus identifies subtypes of sporadic pseudohypoparathyroidism type Ib","volume":"48","author":"Maupetit-Mehouas","year":"2011","journal-title":"J Med Genet"},{"key":"2024020319023760800_jbmr2532-bib-0038","doi-asserted-by":"crossref","first-page":"E508","DOI":"10.1210\/jc.2013-3086","article-title":"Quantitative analysis of methylation defects and correlation with clinical characteristics in patients with pseudohypoparathyroidism type I and GNAS epigenetic alterations","volume":"99","author":"Elli","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"2024020319023760800_jbmr2532-bib-0039","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1086\/320117","article-title":"Paternal uniparental isodisomy of chromosome 20q (patUPD20q)\u2014and the resulting changes in GNAS1 methylation\u2014as a plausible cause of pseudohypoparathyroidism","volume":"68","author":"Bastepe","year":"2001","journal-title":"Am J Hum Genet"},{"key":"2024020319023760800_jbmr2532-bib-0040","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.bone.2010.10.168","article-title":"Paternal uniparental isodisomy of the entire chromosome 20 as a molecular cause of pseudohypoparathyroidism type Ib (PHP-Ib)","volume":"48","author":"Bastepe","year":"2011","journal-title":"Bone"},{"key":"2024020319023760800_jbmr2532-bib-0041","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1530\/EJE-10-0435","article-title":"New mechanisms involved in paternal 20q disomy associated with pseudohypoparathyroidism","volume":"163","author":"Fern\u00e1ndez-Rebollo","year":"2011","journal-title":"Eur J Endocrinol"},{"key":"2024020319023760800_jbmr2532-bib-0042","doi-asserted-by":"crossref","first-page":"E103","DOI":"10.1210\/jc.2012-2639","article-title":"Pseudohypoparathyroidism type 1b due to paternal uniparental disomy of chromosome 20q","volume":"98","author":"Dixit","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"2024020319023760800_jbmr2532-bib-0043","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.1210\/jc.2006-2287","article-title":"Epigenetic defects of GNAS in patients with pseudohypoparathyroidism and mild features of Albright's hereditary osteodystrophy","volume":"92","author":"P\u00e9rez de Nanclares","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"2024020319023760800_jbmr2532-bib-0044","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1097\/MAJ.0b013e31815b218f","article-title":"Molecular diagnosis and clinical characterization of pseudohypoparathyroidism type-Ib in a patient with mild Albright's hereditary osteodystrophy-like features, epileptic seizures, and defective renal handling of uric acid","volume":"336","author":"Unluturk","year":"2008","journal-title":"Am J Med Sci"},{"key":"2024020319023760800_jbmr2532-bib-0045","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1210\/jc.2007-0927","article-title":"A maternal epimutation of GNAS leads to Albright osteodystrophy and parathyroid hormone resistance","volume":"93","author":"Mariot","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"2024020319023760800_jbmr2532-bib-0046","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1210\/jcem-66-3-618","article-title":"Effects of endogenous and exogenous parathyroid hormone on tubular reabsorption of calcium in pseudohypoparathyroidism","volume":"66","author":"Yamamoto","year":"1988","journal-title":"J Clin Endocrinol Metab"},{"key":"2024020319023760800_jbmr2532-bib-0047","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1007\/BF00441552","article-title":"Biochemical markers of bone turnover, intact serum parathyroid hormone and renal calcium excretion in patients with pseudohypoparathyroidism and hypoparathyroidism before and during vitamin D treatment","volume":"148","author":"Kruse","year":"1989","journal-title":"Eur J Pediatr"},{"key":"2024020319023760800_jbmr2532-bib-0048","doi-asserted-by":"crossref","first-page":"4507","DOI":"10.1210\/jc.2012-1808","article-title":"Long-term follow-up of patients with hypoparathyroidism","volume":"97","author":"Mitchell","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"2024020319023760800_jbmr2532-bib-0049","doi-asserted-by":"crossref","first-page":"3068","DOI":"10.1210\/endo.142.7.8253","article-title":"Enhanced activity in parathyroid hormone (1-14) and (1-11): novel peptides for probing the ligand-receptor interaction","volume":"142","author":"Shimizu","year":"2001","journal-title":"Endocrinology"},{"key":"2024020319023760800_jbmr2532-bib-0050","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1046\/j.1523-1755.2003.00915.x","article-title":"Similar predictive value of bone turnover using first- and second-generation immunometric PTH assays in pediatric patients treated with peritoneal dialysis","volume":"63","author":"Salusky","year":"2003","journal-title":"Kidney Int"},{"key":"2024020319023760800_jbmr2532-bib-0051","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/j.clinbiochem.2013.01.016","article-title":"Comparison of the Elecsys PTH(1-84) assay with four contemporary second generation intact PTH assays and association with other biomarkers in chronic kidney disease patients","volume":"46","author":"Tan","year":"2013","journal-title":"Clin Biochem"},{"key":"2024020319023760800_jbmr2532-bib-0052","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1210\/en.2012-2240","article-title":"Activation of a non-cAMP\/PKA signaling pathway downstream of the PTH\/PTHrP receptor is essential for a sustained hypophosphatemic response to PTH infusion in male mice","volume":"154","author":"Guo","year":"2013","journal-title":"Endocrinology"},{"key":"2024020319023760800_jbmr2532-bib-0053","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1038\/nbt.2920","article-title":"Backbone modification of a polypeptide drug alters duration of action in vivo","volume":"32","author":"Cheloha","year":"2014","journal-title":"Nat Biotech"},{"key":"2024020319023760800_jbmr2532-bib-0054","doi-asserted-by":"crossref","first-page":"32485","DOI":"10.1074\/jbc.M606179200","article-title":"Role of amino acid side chains in region 17-31 of parathyroid hormone (PTH) in binding to the PTH receptor","volume":"281","author":"Dean","year":"2006","journal-title":"J Biol Chem"},{"key":"2024020319023760800_jbmr2532-bib-0055","doi-asserted-by":"crossref","first-page":"5864","DOI":"10.1073\/pnas.1301674110","article-title":"Critical role of parathyroid hormone (PTH) receptor-1 phosphorylation in regulating acute responses to PTH","volume":"110","author":"Maeda","year":"2013","journal-title":"Proc Natl Acad Sci USA"},{"key":"2024020319023760800_jbmr2532-bib-0056","doi-asserted-by":"crossref","first-page":"2218","DOI":"10.1056\/NEJMoa1012717","article-title":"Recurrent PRKAR1A mutation in acrodysostosis with hormone resistance","volume":"364","author":"Linglart","year":"2011","journal-title":"N Engl J Med"},{"key":"2024020319023760800_jbmr2532-bib-0057","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1101\/gr.092841.109","article-title":"The ClinSeq Project: piloting large-scale genome sequencing for research in genomic medicine","volume":"19","author":"Biesecker","year":"2009","journal-title":"Genome Res"},{"key":"2024020319023760800_jbmr2532-bib-0058","doi-asserted-by":"crossref","first-page":"28382","DOI":"10.1074\/jbc.M109.022905","article-title":"Structural basis for parathyroid hormone-related protein binding to the parathyroid hormone receptor and design of conformation-selective peptides","volume":"284","author":"Pioszak","year":"2009","journal-title":"J Biol Chem"},{"key":"2024020319023760800_jbmr2532-bib-0059","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1093\/clinchem\/36.2.271","article-title":"Immunoradiometric assay of parathyrin with polyclonal and monoclonal region-specific antibodies","volume":"36","author":"Bouillon","year":"1990","journal-title":"Clin Chem"},{"key":"2024020319023760800_jbmr2532-bib-0060","doi-asserted-by":"crossref","first-page":"4287","DOI":"10.1210\/jcem.84.11.6236","article-title":"A novel immunoradiometric assay detects full-length human PTH but not amino-terminally truncated fragments: implications for PTH measurements in renal failure","volume":"84","author":"John","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"2024020319023760800_jbmr2532-bib-0061","first-page":"1840","article-title":"Optimal range of plasma concentration of true 1-84 parathyroid hormone in patients on maintenance dialysis","volume":"86","author":"Fournier","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"2024020319023760800_jbmr2532-bib-0062","doi-asserted-by":"crossref","first-page":"103","DOI":"10.2174\/138945012798868434","article-title":"The family B1 GPCR: structural aspects and interaction with accessory proteins","volume":"13","author":"Couvineau","year":"2012","journal-title":"Curr Drug Targets"},{"key":"2024020319023760800_jbmr2532-bib-0063","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.tips.2012.05.004","article-title":"Non-canonical signaling of the PTH receptor","volume":"33","author":"Vilardaga","year":"2012","journal-title":"Trends Pharmacol Sci"},{"key":"2024020319023760800_jbmr2532-bib-0064","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/B978-0-12-397166-1.00006-0","volume-title":"The parathyroids: basic and clinical concepts","author":"Brown","year":"2015"},{"key":"2024020319023760800_jbmr2532-bib-0065","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1056\/NEJMc0802570","article-title":"PTH mutation with primary hyperparathyroidism and undetectable intact PTH","volume":"359","author":"Au","year":"2008","journal-title":"N Engl J Med"},{"key":"2024020319023760800_jbmr2532-bib-0066","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1038\/nature12357","article-title":"Structure of class B GPCR corticotropin-releasing factor receptor 1","volume":"499","author":"Hollenstein","year":"2013","journal-title":"Nature"}],"container-title":["Journal of Bone and Mineral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fjbmr.2532","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fjbmr.2532","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/jbmr\/article-pdf\/30\/10\/1803\/56567265\/jbmr2532.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jbmr\/article-pdf\/30\/10\/1803\/56567265\/jbmr2532.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,13]],"date-time":"2024-03-13T10:54:15Z","timestamp":1710327255000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jbmr\/article\/30\/10\/1803-1813\/7599135"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4,18]]},"references-count":66,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2015,4,18]]},"published-print":{"date-parts":[[2015,10,1]]}},"URL":"https:\/\/doi.org\/10.1002\/jbmr.2532","relation":{},"ISSN":["0884-0431","1523-4681"],"issn-type":[{"value":"0884-0431","type":"print"},{"value":"1523-4681","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2015,10,1]]},"published":{"date-parts":[[2015,4,18]]}}}